{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:04Z","timestamp":1793409664113,"version":"4.5.0"},"reference-count":47,"publisher":"Codon Publications","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["32345"],"award-info":[{"award-number":["32345"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.aller.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T20:31:16Z","timestamp":1498941076000},"page":"263-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["MHC class II deficiency: Report of a novel mutation and special review"],"prefix":"10.15586","volume":"46","author":[{"given":"S.","family":"Farrokhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Aryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zoghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Krolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Boztug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2017.04.006_bib0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10875-014-0048-x","article-title":"Major histocompatibility complex class II deficiency complicated by Mycobacterium avium complex in a boy of mixed ethnicity","volume":"34","author":"Dimitrova","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2013.00476","article-title":"CIITA and its dual roles in MHC gene transcription","volume":"4","author":"Devaiah","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0150","first-page":"164","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"2014","author":"Al-Herz","year":"2013","journal-title":"Proc ICI Milan"},{"key":"10.1016\/j.aller.2017.04.006_bib0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/emboj\/16.5.1045","article-title":"RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency","volume":"16","author":"Durand","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.aller.2017.04.006_bib0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(05)80388-9","article-title":"Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome","volume":"123","author":"Klein","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2017.04.006_bib0165","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00431-010-1179-6","article-title":"The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population","volume":"169","author":"Naamane","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.aller.2017.04.006_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-8-14","article-title":"Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency","volume":"8","author":"Djidjik","year":"2012","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10875-013-9863-8","article-title":"Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients","volume":"33","author":"Ben-Mustapha","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0180","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","article-title":"Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients","volume":"118","author":"Ouederni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.aller.2017.04.006_bib0185","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1097\/MPH.0000000000000278","article-title":"Type II bare lymphocyte syndrome: role of peripheral blood flow cytometry and utility of stem cell transplant in treatment","volume":"37","author":"Kallen","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.aller.2017.04.006_bib0190","first-page":"219","article-title":"A case of probable MHC class II deficiency with disseminated BCGitis","volume":"12","author":"Alyasin","year":"2015","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","article-title":"Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)","volume":"75","author":"Steimle","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.aller.2017.04.006_bib0200","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00251-001-0395-7","article-title":"Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency","volume":"53","author":"Dziembowska","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s004390050403","article-title":"Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A","volume":"99","author":"Bontron","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.aller.2017.04.006_bib0210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000288292","article-title":"Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels","volume":"152","author":"Schmetterer","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002510050619","article-title":"Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B","volume":"51","author":"Wiszniewski","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00251-002-0521-1","article-title":"Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II","volume":"54","author":"Wiszniewski","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/271459a0","article-title":"Stable variants affecting B cell alloantigens in human lymphoid cells","volume":"271","author":"Gladstone","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.aller.2017.04.006_bib0230","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1111\/j.1399-3046.2010.01292.x","article-title":"MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature","volume":"15","author":"Siepermann","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.aller.2017.04.006_bib0235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10875-012-9831-8","article-title":"Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile","volume":"33","author":"Al-Herz","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0240","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.aller.2017.04.006_bib0245","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2141.2006.06213.x","volume":"134","author":"Renella","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.aller.2017.04.006_bib0250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bmt.2012.140","article-title":"Alternative donor SCT for the treatment of MHC class II deficiency","volume":"48","author":"Small","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.aller.2017.04.006_bib0255","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbmt.2010.01.002","article-title":"Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency","volume":"16","author":"Al-Mousa","year":"2010","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.aller.2017.04.006_bib0260","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jaci.2013.01.019","article-title":"Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome","volume":"131","author":"Kuo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0265","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.167.3.1787","article-title":"Mutation in the class II trans-activator leading to a mild immunodeficiency","volume":"167","author":"Wiszniewski","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002510050007","article-title":"Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene","volume":"51","author":"Peijnenburg","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0275","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s002510050579","article-title":"Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA","volume":"49","author":"Quan","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0280","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/hmg\/7.5.879","article-title":"Genetic and molecular definition of complementation group D in MHC class II deficiency","volume":"7","author":"Fondaneche","year":"1998","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.aller.2017.04.006_bib0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/08820139109050783","article-title":"Cell-mediated immune functions in a patient with MHC class II deficiency","volume":"20","author":"Mannhalter","year":"1991","journal-title":"Immunol Invest"},{"key":"10.1016\/j.aller.2017.04.006_bib0290","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1093\/jimmunol\/178.11.6677","article-title":"Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)","volume":"178","author":"Steimle","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-7961-10-6","article-title":"Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome)","volume":"10","author":"Guirat-Dhouib","year":"2012","journal-title":"Clin Mol Allergy: CMA"},{"key":"10.1016\/j.aller.2017.04.006_bib0300","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00251-003-0609-2","article-title":"Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course","volume":"55","author":"Prod\u2019homme","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0305","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.166.9.5681","article-title":"Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency,","volume":"166","author":"Lennon-Dumenil","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0310","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.164.7.3666","article-title":"Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells","volume":"164","author":"Nagarajan","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0315","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/hmg\/3.6.953","article-title":"Two complementation groups account for most cases of inherited MHC class II deficiency","volume":"3","author":"Lisowska-Grospierre","year":"1994","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.aller.2017.04.006_bib0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1074-7613(00)80016-3","article-title":"RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency","volume":"10","author":"Nagarajan","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.aller.2017.04.006_bib0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/3081","article-title":"A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients","volume":"20","author":"Masternak","year":"1998","journal-title":"Nature Genet"},{"key":"10.1016\/j.aller.2017.04.006_bib0330","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ni840","article-title":"Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome","volume":"3","author":"Nekrep","year":"2002","journal-title":"Nature Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0335","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.163.2.794","article-title":"Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5","volume":"163","author":"Peijnenburg","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0340","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002510050501","article-title":"Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene","volume":"49","author":"Peijnenburg","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.aller.2017.04.006_bib0345","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<430::AID-HUMU3>3.0.CO;2-H","article-title":"Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency","volume":"10","author":"Villard","year":"1997","journal-title":"Human Mut"},{"key":"10.1016\/j.aller.2017.04.006_bib0350","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","article-title":"A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)","volume":"9","author":"Steimle","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.aller.2017.04.006_bib0355","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.molimm.2008.01.026","article-title":"Transcriptional silencing of RFXAP in MHC class II-deficiency","volume":"45","author":"van Eggermond","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.aller.2017.04.006_bib0360","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0171-2985(97)80046-0","article-title":"MHC class II deficiency: definition of a new complementation group","volume":"198","author":"Villard","year":"1997","journal-title":"Immunobiology"},{"key":"10.1016\/j.aller.2017.04.006_bib0365","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM199709113371104","article-title":"Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency","volume":"337","author":"Villard","year":"1997","journal-title":"N Engl J Med"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054617300770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054617300770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T21:47:37Z","timestamp":1750456057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054617300770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0301054617300770"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2017.04.006","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MHC class II deficiency: Report of a novel mutation and special review","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}